Use of N-acetylcysteine prior to cardiac catheterization to prevent acute renal injury in patients with stage III chronic kidney disease

Harefuah

Volumn 146, Issue 9, 2007, Pages 655-659

  Shavit, Linda ^a   Lifschitz, Meyer ^a   Lachish, Tamar ^a   Rosenmann, David ^a   Balkin, Jonathan ^a   Slotki, Itzchak ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Contrast induced nephropathy; N acetylcysteine; Renal insufficiency

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

ACETYLCYSTEINE; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GLOMERULAR FILTRATION RATE; HEART CATHETERIZATION; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 38449107441     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Heyman SN & Rosen S, Dye-induced nephropathy, Semin Nephrol, 2003; 23: 477-485.
2. Birck R, Krzossok S, Markowetz F & al, NAC for prevention of contrast nephropathy: Meta-analysis. Lancet, 2003; 362: 598-603.
3. Kshirsagar AV, Poole C, Mottl A & al, N-Acetylcysteine for the Prevention of Radiocontrast Induced Nephropathy: A Meta-Analysis of Prospective Controlled Trials. J Am Soc Nephrol, 2004; 15: 761-769.
4. Barret B & Parfrey PS, Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med, 2006; 354: 379-86.
5. Zagler A, Azadpour M, Mercado C & Hennekens CH, N-sacetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials Am Heart J, 2006; 151: 140-5.
6. Tepel M, Van Der Giet M, Schwarzfeld C & al, Prevention of radiographic-contrast-agent-induced reductions in renal function byacetylcysteine. N Engl J Med, 2000; 343: 180-184.
7. Levey AS, Bosch JP, Lewis JB & al, A more accurate method to estimate glomerular filtration rate from serum creatinine: a New Prediction Equation. Ann Intern Med, 1999; 130: 461-470.
8. Hoffmann U, Fischereder M, Kruger B & al, The value of N-Acetylcysteine in the prevention of Radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol, 2004; 15: 407-410.
9. Efrati S, Dishy V, Averbukh M & al, The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int, 2003; 64: 2182-2187.
10. Merten GJ, Burgess WP, Gray LV & al, Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA, 2004; 291: 2328-2334.
11. Weinstein JM, Heyman S & Brezis M, Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron, 1992; 62: 413-415.
12. Solomon R, Werner C, Mann D & al, Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Eng J Med, 1994; 331: 1416-1420.
13. Stevens MA, McCullough PA, Tobin KJ & al, A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. J Am Coll Cardiol, 1999; 33: 403-411.
14. Kurnik BR, Allgren RL, Genter FC & al, Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis, 1998; 31: 674-680.
15. Stone GW, McCullough PA, Tumlin JA & al, Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA, 2003; 290: 2284-2291.
16. 1: a randomized, double-blind, placebo-controlled study. Am J Ther, 2001; 8: 155-162.
17. Khoury Z, Schlicht JR, Como J & al, The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacotherapy, 1995; 15: 59-65.
18. Gupta RK, Kapoor A, Tewari S & al, Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J, 1999; 51: 521-526.
19. Marenzi G, Gianfranco L, Jeness C & al, Comparison of two hemofiltration protocols for prevention of contrast of contrast-induced nephropathy in high-risk patients. Am J Med, 2006; 119: 155-162.
20. Marenzi G, Ivana M, Gianfranco L & al, The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. New Eng J Med, 2003; 349: 1333-1340.